BMJ

Khoáng sản Miền Đông AHP ·UPCOM ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 15.07%, +6.13pp YoY
Price
11,400
Latest close
20 May 2026
P/E 12.54x
P/B 0.85x
EPS 909
BVPS 13,406
ROE 7.2%
ROA 5.3%
Profit Margin 15.1%
Asset Turnover 0.35x
Equity Mult. 1.36x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, BMJ has not accelerated revenue sharply, but profitability is improving visibly — profit is at an all-time high. However, operating cash flow is significantly negative relative to profit — this needs monitoring in coming periods.

TTM REVENUE
VND 633bn
+7.8%YoY
NET MARGIN
15.07%
+6.1ppYoY
TTM NET PROFIT
VND 95bn
+81.7%YoY
CFO / Net Income
-0.80x
negative cash flow vs profit
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 131.8 92.5 207.5 201.5 115.4 228.2 132.0 111.9 63.0 115.7 132.1 110.4
Growth +42% -55% +3% +75% -49% +73% +18% +78% -46% -12% +20%
Net Income 11.1 45.0 15.3 24.1 12.3 11.7 10.8 17.7 8.3 12.0 11.9 18.4
Net Margin 8.41% 48.58% 7.36% 11.97% 10.64% 5.13% 8.20% 15.82% 13.22% 10.39% 9.03% 16.67%

Drivers of BMJ's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 41.3bn
Financial income ↑ 7.9bn
Tax ↑ 10.2bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to lower financial income. Supporting and offsetting drivers:

Selling expenses ↓ 1.3bn
Gross profit ↑ 0.8bn
Tax ↓ 0.3bn
Financial income ↓ 3.2bn
Administrative expenses ↑ 0.4bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 4.4% = 8.9% × 0.37 × 1.34
2026Q1 7.2% = 15.1% × 0.35 × 1.36

ROE rose from 4.4% to 7.2% — mainly driven by net margin, despite asset turnover moving in the opposite direction.

Net margin: 15.1% +6.1pp Asset turnover: 0.35x -0.01x Leverage: 1.36x +0.02x

Is the profit sustainable?

Accounting profit is positive but operating cash flow has not caught up — needs more time to confirm.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 15.07%, rising 6.1pp. The main driver is Gross margin rose 5.4pp, moving in line with the stronger net margin (with additional support from Net financial result / Revenue rose 1.1pp and Other profit / Revenue rose 0.6pp).

The improvement comes from core operations — this is a high-quality margin expansion.

Profitability trend

Net Margin 15.07% +6.1pp
Gross Margin 20.87% +5.4pp
SG&A / Revenue 3.89% −0.2pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 74.0 days — working capital needs watching.

Is capital being deployed efficiently?

ROIC expanded to 5.78%, rising 2.0pp. That translates to 5.78 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 5.6pp, with capital turnover broadly stable; while invested capital rose by 192bn.

NOPAT margin is the main cushion preventing ROIC from slipping as invested capital keeps expanding — the quality of this improvement depends on whether margin holds once the new capital is fully deployed.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 5.78% +2.0pp
NOPAT Margin 14.61% +5.6pp
Capital Turnover 0.40x −0.02x
Average Invested Capital 1,602.1bn +191.7bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is conservative with low leverage — liabilities at 0.34x equity, net debt at 0.25x equity.

Inventory ended the period at 308.4bn, roughly 16.4% of total assets.

Over the last 12 months, working capital absorbed 150.3bn of cash, mainly because of higher inventories and lower payables. Part of that drag was offset by lower receivables.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables decreased → higher CFO: +13.9bn
Inventories increased → lower CFO: −161.7bn
Payables decreased → lower CFO: −2.5bn

Working Capital Efficiency

Cash conversion cycle lengthened by 74.0 days versus the same period last year. The main moves came from DIO rose 62.6 days, DSO rose 2.2 days, and DPO fell 9.2 days.

All 3 drivers are deteriorating — working capital is becoming more deeply tied up in the operating cycle.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 170.0 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +2.2 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 20.1 days +2.2 days
Inventory 174.8 days +62.6 days
Payables 24.9 days −9.2 days
Cash Conversion Cycle 170.0 days +74.0 days

Is financial risk significant?

Leverage is safe but FCF is negative at 117.0bn due to capex of 41.1bn — an investment choice, not an urgent risk.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at 0.25x and interest coverage at 4.40x.

At present, short-term debt accounts for 91.7% of total debt, cash equals 4.5% of debt, and total debt stands at 368.6bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 91.7% of total debt, raising near-term refinancing needs.

Cash buffer is thin relative to debt

Cash / debt stands at 4.5%, leaving limited liquidity buffer to monitor.

Leverage and liquidity trend

Net Debt / Equity 0.25x +0.07x
Interest Coverage 4.40x +1.77x
Cash / Debt 4.5% −35.2pp
Short-term Debt / Total Debt 91.7% +8.1pp
CFO / NI -0.80x −1.36x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 19.1bn in 2025, against investing cash flow of -21.8bn.

Post-investment cash flow was negative +2.6bn. Financing cash flow was positive +6.0bn.

CFO / net income was -0.80x.

After spending +41.1bn on fixed-asset investment, the business generated trailing free cash flow of −117.0bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 76.0bn −105.7bn
Cash Capex 41.1bn
FCF TTM −117.0bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 6.1 pp. The main risk still sits in leverage and liquidity, with interest coverage at 4.40x.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 15.07% after expanding 6.1pp versus the same period last year.

Key risk: leverage and liquidity remain a pressure point, with net debt / equity at 0.25x and a thin cash buffer.

Statement Data

Item 2025 2024 2023 2022
Net Revenue
616.9 535.1 454.1 200.6
Cost of Goods Sold
485.7 457.0 372.9 163.3
Gross Profit
131.2 78.0 81.2 37.3
Financial Expenses
27.0 22.8 12.0 1.5
Selling Expenses
11.4 10.1 15.7 4.3
General and Administrative Expenses
14.4 11.8 9.8 8.0
Operating Profit
116.0 60.8 58.2 33.2
Profit Before Tax
119.4 60.7 65.8 32.9
Net Income
95.8 48.5 52.7 26.1
Profit Attributable to Parent
95.8 48.5 52.7 26.1
Earnings per Share
913.00 462.00 502.00 130.00

Explore Other Stocks In The Same Sector

VCS, VLB, HT1, MVC, THG, KSB, NNC, LBM, FIC, DHA, LIC, HUB, VIT, MTA, TLD, SCL, PDB, CVT, MDG, CLH, RYG, QNC, BTS, CMD, HCC, S74, VHL, PCC, YBM, VCX, CCM, C32, BCC, GND, HOM, TRT, TLT, BTD, TNT, FCM, GMH, GMX, ACE, KHD, SCJ, VIH, CDG, CQT, BDT, YBC, AMC, SDY, KSQ, NHC, EME, TMX, TAB, XMD, TDF, DDB, DAC, MCC, HMR, TTC, NXT, DID, TCR, DIC, MIC, VIM, DXV, VTS, HPM, TXM, SCC, DCR, DKG, LMC, GKM, BHC, TTZ, X77, LQN, VHH, SPI, BTN, HLY, DGT, VTA, CMI, DTC, DND, ILA, CYC, LCC, PTE, HVX, BT6, DCT, CTA, KHL, PX1

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.